Get started
Author

M Nam

Observed names: M. Nam, M.H. Lucy Nam
OpenAlex ID: A5108612902
Can multiplexing Immunohistochemistry for PD-L1, CD68, and CD3 improve scoring for “Keytruda®” Indication?
2024 · S Melvin, M Nam · American Journal of Clinical Pathology
Key Considerations when Evaluating Whether to Establish a PD-L1 Laboratory Developed Test (LDT)
2023 · Y Hung, X Liu, et al. · American Journal of Clinical Pathology
PDF
RET Fusion Detection Using IdyllaTM Gene Fusion Assay
2023 · A Nutcharoen, N Hoo-Fatt, et al. · American Journal of Clinical Pathology
PDF
Endometrial Cancer and Molecular Methods: A Case Study of MSI Heterogeneity based on Metastatic Location with IdyllaTM
2022 · A Degner, M Nam, et al. · American Journal of Clinical Pathology
PDF
Clinical Application of Rapid PCR and Computational Digital Pathology for Cancer Diagnostics: A showcase for Advanced Lung Cancer Management
2022 · N Hoo-Fatt, A Ullah, et al. · American Journal of Clinical Pathology
A MD3100: Successful Mobilization in Patients Who Fail Standard Mobilization With Good Transplant Outcome and No Significant Toxicity
2009 · G.T. Kannarkat, R. Beveridge, et al. · Transplantation and Cellular Therapy
Integrating point-of-care and automated methods for cardiac testing
2008 · M. Nam, J. Lynch, et al. · Clinical Biochemistry
Works count: 7
Citation count:
H-index:
I10-index:
Year
Topic
Type